HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets

The gut microbiota plays a key role in health and immune system education and surveillance. The delicate balance between microbial growth and containment is controlled by the immune system. However, this balance is disrupted in cases of chronic viral infections such as HIV. This virus is capable of...

Full description

Saved in:
Bibliographic Details
Main Authors: Kishanda Vyboh, Mohammad-Ali Jenabian, Vikram Mehraj, Jean-Pierre Routy
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2015/614127
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555953295196160
author Kishanda Vyboh
Mohammad-Ali Jenabian
Vikram Mehraj
Jean-Pierre Routy
author_facet Kishanda Vyboh
Mohammad-Ali Jenabian
Vikram Mehraj
Jean-Pierre Routy
author_sort Kishanda Vyboh
collection DOAJ
description The gut microbiota plays a key role in health and immune system education and surveillance. The delicate balance between microbial growth and containment is controlled by the immune system. However, this balance is disrupted in cases of chronic viral infections such as HIV. This virus is capable of drastically altering the immune system and gastrointestinal environment leading to significant changes to the gut microbiota and mucosal permeability resulting in microbial translocation from the gut into the peripheral blood. The changes made locally in the gut have far-reaching consequences on the other organs of the body starting in the liver, where microbes and their products are normally filtered out, and extending to the blood and even brain. Microbial translocation and their downstream effects such as increased indolamine 2,3-dioxygenase (IDO) enzyme expression and activity create a self-sustaining feedback loop which enhances HIV disease progression and constitute a vicious cycle of inflammation and immune activation combining viral and bacterial factors. Understanding this self-perpetuating cycle could be a key element in developing new therapies aimed at the gut microbiota and its fallout after infection.
format Article
id doaj-art-c1e08ed1b98f4166ae5ea71f7bc60aaf
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-c1e08ed1b98f4166ae5ea71f7bc60aaf2025-02-03T05:46:51ZengWileyJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/614127614127HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic TargetsKishanda Vyboh0Mohammad-Ali Jenabian1Vikram Mehraj2Jean-Pierre Routy3Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, QC, H2X 2P4, CanadaChronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, QC, H2X 2P4, CanadaChronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, QC, H2X 2P4, CanadaChronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, QC, H2X 2P4, CanadaThe gut microbiota plays a key role in health and immune system education and surveillance. The delicate balance between microbial growth and containment is controlled by the immune system. However, this balance is disrupted in cases of chronic viral infections such as HIV. This virus is capable of drastically altering the immune system and gastrointestinal environment leading to significant changes to the gut microbiota and mucosal permeability resulting in microbial translocation from the gut into the peripheral blood. The changes made locally in the gut have far-reaching consequences on the other organs of the body starting in the liver, where microbes and their products are normally filtered out, and extending to the blood and even brain. Microbial translocation and their downstream effects such as increased indolamine 2,3-dioxygenase (IDO) enzyme expression and activity create a self-sustaining feedback loop which enhances HIV disease progression and constitute a vicious cycle of inflammation and immune activation combining viral and bacterial factors. Understanding this self-perpetuating cycle could be a key element in developing new therapies aimed at the gut microbiota and its fallout after infection.http://dx.doi.org/10.1155/2015/614127
spellingShingle Kishanda Vyboh
Mohammad-Ali Jenabian
Vikram Mehraj
Jean-Pierre Routy
HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
Journal of Immunology Research
title HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
title_full HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
title_fullStr HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
title_full_unstemmed HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
title_short HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
title_sort hiv and the gut microbiota partners in crime breaking the vicious cycle to unearth new therapeutic targets
url http://dx.doi.org/10.1155/2015/614127
work_keys_str_mv AT kishandavyboh hivandthegutmicrobiotapartnersincrimebreakingtheviciouscycletounearthnewtherapeutictargets
AT mohammadalijenabian hivandthegutmicrobiotapartnersincrimebreakingtheviciouscycletounearthnewtherapeutictargets
AT vikrammehraj hivandthegutmicrobiotapartnersincrimebreakingtheviciouscycletounearthnewtherapeutictargets
AT jeanpierrerouty hivandthegutmicrobiotapartnersincrimebreakingtheviciouscycletounearthnewtherapeutictargets